The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

ダウンロード数 : ? 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/52932

言語	英語
著者	Akamatsu, Hiroaki Internal Medicine III, Wakayama Medical University, Wakayama, Japan Ninomiya, Kiichiro Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan Kenmotsu, Hirotsugu Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan Morise, Masahiro Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Aichi, Japan Daga, Haruko Osaka City General Hospital, Osaka, Japan Goto, Yasushi Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan Kozuki , Toshiyuki Clinical Research Center, Department of Thoracic Oncology and Medicine, National Hospital Organization Shikoku Cancer Center, Ehime, Japan Miura, Satoru Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan Sasaki, Takaaki Respiratory Center, Asahikawa Medical University Hospital, Hokkaido, Japan Tamiya, Akihiro National Hospital Organization Kinki-chuo Chest Medical Center, Osaka, Japan Teraoka, Shunsuke Internal Medicine III, Wakayama Medical University, Wakayama, Japan 津端由佳里 Yoshioka , Hiroshige Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan Hattori, Yoshihiro Department of Thoracic Oncology, Hyogo Cancer Center, Hyogo, Japan Imamura , Chiyo K. Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan Katsuya, Yuki Department of Surgery, University of California San Diego, California, USA Matsui, Reiko National Cancer Center Hospital East, Chiba, Japan Minegishi, Yuji Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan Mizugaki, Hidenori First Department of Medicine, Hokkaido University Hospital, Hokkaido, Japan Nosaki, Kaname Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan Okuma, Yusuke Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan Sakamoto, Setsuko Kyushu University Hospital, Fukuoka, Japan Sone, Takashi Regional Respiratory Symptomatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan Tanaka, Kentaro Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan Umemura, Shigeki Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan Yamanaka, Takeharu Department of Biostatistics, Yokohama City University School of Medicine, Kanagawa, Japan Amano, Shinsuke Japan Federation of Cancer Patient Groups, Tokyo, Japan Hasegawa, Kazuo Japan Lung Cancer Alliance, Tokyo, Japan Morita, Satoshi Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan Nakajima, Kazuko Shizuoka Cancer Center, Shizuoka, Japan Maemondo, Makoto Division of Pulmonary Medicine, Allergry and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Iwate, Japan Seto, Takashi Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan Yamamoto, Nobuyuki Internal Medicine III, Wakayama Medical University, Wakayama, Japan
主題	Non-small cell lung cancer; Chemotherapy; Kinase inhibitor; Programed cell death-1 inhibitor; Programed death-ligand 1 inhibitor; Guideline
掲載誌名	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
巻	24
号	7
開始ページ	731
終了ページ	770
ISSN	1341-9625
ISSN（Online）	1437-7772
発行日	2019-07
DOI	10.1007/s10147-019-01431-z
PubMed ID	31049758
出版者	SPRINGER JAPAN KK
資料タイプ	学術雑誌論文
部局	医学部
備考	Preparation of these guidelines was funded by Japanese Lung Cancer Society. We did not receive any financial support from other organizations or companies.